HOLLY SHOURD: Open Payments
NPI 1598326233 · JACKSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,919 in 90 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $870 · 2025 $1,919
Food & beverage: $1,919
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $405 |
| Axsome Therapeutics, Inc. | 13 | $257 |
| ABBVIE INC. | 6 | $168 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $167 |
| Lilly USA, LLC | 15 | $155 |
| Amgen Inc. | 8 | $151 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| Merck Sharp & Dohme LLC | 1 | $96 |
| AstraZeneca Pharmaceuticals LP | 4 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
Products named: Auvelity, Wegovy, JARDIANCE, VRAYLAR, MOUNJARO, OTEZLA, AREXVY, Ozempic.
Industry payments across TN — which companies pay providers there.
